7CDJ
Crystal structure of SARS-CoV-2 antibody P2C-1A3 with RBD
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U |
Synchrotron site | SSRF |
Beamline | BL17U |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2020-05-01 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.9796 |
Spacegroup name | P 61 2 2 |
Unit cell lengths | 89.411, 89.411, 437.923 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 20.312 - 3.396 |
R-factor | 0.2334 |
Rwork | 0.231 |
R-free | 0.27090 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6m0j |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX (1.15_3459) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.312 | 3.480 |
High resolution limit [Å] | 3.396 | 3.400 |
Rmerge | 0.118 | 0.933 |
Number of reflections | 15108 | 1322 |
<I/σ(I)> | 8.8 | |
Completeness [%] | 99.7 | |
Redundancy | 8.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 298 | 0.1M lithium sulfate monohydrate, 0.1M citric acid, pH 3.5, 18% PEG 6000 |